R. Ramelmeier
Chief Tech/Sci/R&D Officer chez ADVERUM BIOTECHNOLOGIES, INC.
Fortune : 59 014 $ au 31/03/2024
Profil
R.
Andrew Ramelmeier is currently the Chief Technology Officer at Adverum Biotechnologies, Inc. He previously held positions as the Executive Director-Pharmaceutical Development at Centocor, Inc. from 2001 to 2005, Vice President-Process Sciences at Johnson & Johnson, VP-Manufacturing, Process Sciences & Facilities at BioMarin Pharmaceutical, Inc. from 2006 to 2014, Senior Vice President-Technical Operations at Portola Pharmaceuticals LLC from 2014 to 2017, and Chief Manufacturing & Quality Officer, Senior VP at Sangamo Therapeutics, Inc. from 2018 to 2023.
He obtained his undergraduate degree from The Johns Hopkins University in 1984 and his doctorate degree from the University of California, Berkeley in 1989.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
25/05/2023 | 88 080 ( 0,04% ) | 59 014 $ | 31/03/2024 |
Postes actifs de R. Ramelmeier
Sociétés | Poste | Début |
---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 21/08/2023 |
Anciens postes connus de R. Ramelmeier
Sociétés | Poste | Fin |
---|---|---|
SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 10/07/2023 |
PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2014 |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | 01/01/2005 |
JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Formation de R. Ramelmeier
The Johns Hopkins University | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
JOHNSON & JOHNSON | Health Technology |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
SANGAMO THERAPEUTICS, INC. | Health Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |